MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis

Naoki Ohmiya, Ayumu Taguchi, Nobuyuki Mabuchi, Akihiro Itoh, Yoshiki Hirooka, Yasumasa Niwa, Hidemi Goto

Research output: Contribution to journalArticlepeer-review

124 Citations (Scopus)

Fingerprint

Dive into the research topics of 'MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science